QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
Log in
NASDAQ:SYBX

Synlogic Stock Forecast, Price & News

$2.12
+0.06 (+2.91 %)
(As of 11/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.07
Now: $2.12
$2.17
50-Day Range
$1.85
MA: $2.02
$2.15
52-Week Range
$1.35
Now: $2.12
$3.46
Volume253,459 shs
Average Volume301,842 shs
Market Capitalization$73.85 million
P/E RatioN/A
Dividend YieldN/A
Beta2.12
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase I/IIa clinical trial to treat phenylketonuria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with Ginkgo Bioworks for the development of synthetic biotic medicines. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.
Read More
Synlogic logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.62 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SYBX
CUSIPN/A
Phone617-401-9975
Employees76

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.22 million
Book Value$4.86 per share

Profitability

Net Income$-51,370,000.00
Net Margins-2,761.83%

Miscellaneous

Market Cap$73.85 million
Next Earnings Date3/11/2021 (Estimated)
OptionableNot Optionable
$2.12
+0.06 (+2.91 %)
(As of 11/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SYBX News and Ratings via Email

Sign-up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Synlogic (NASDAQ:SYBX) Frequently Asked Questions

How has Synlogic's stock price been impacted by COVID-19 (Coronavirus)?

Synlogic's stock was trading at $1.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SYBX shares have increased by 37.7% and is now trading at $2.12.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Synlogic?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Synlogic in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Synlogic
.

What stocks does MarketBeat like better than Synlogic?

Wall Street analysts have given Synlogic a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Synlogic wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Synlogic's next earnings date?

Synlogic is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for Synlogic
.

How were Synlogic's earnings last quarter?

Synlogic, Inc. (NASDAQ:SYBX) issued its earnings results on Thursday, November, 5th. The biotechnology company reported ($0.36) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.47) by $0.11. Synlogic had a negative net margin of 2,761.83% and a negative return on equity of 38.34%.
View Synlogic's earnings history
.

When did Synlogic's stock split? How did Synlogic's stock split work?

Synlogic's stock reverse split before market open on Monday, August 28th 2017. The 1-7 reverse split was announced on Friday, August 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 25th 2017. An investor that had 100 shares of Synlogic stock prior to the reverse split would have 14 shares after the split.

What price target have analysts set for SYBX?

3 analysts have issued twelve-month price objectives for Synlogic's stock. Their forecasts range from $5.00 to $13.00. On average, they expect Synlogic's share price to reach $9.00 in the next year. This suggests a possible upside of 324.5% from the stock's current price.
View analysts' price targets for Synlogic
.

Are investors shorting Synlogic?

Synlogic saw a increase in short interest in October. As of October 30th, there was short interest totaling 393,600 shares, an increase of 49.1% from the October 15th total of 264,000 shares. Based on an average trading volume of 166,300 shares, the days-to-cover ratio is currently 2.4 days. Currently, 1.9% of the shares of the company are short sold.
View Synlogic's Short Interest
.

Who are some of Synlogic's key competitors?

What other stocks do shareholders of Synlogic own?

Who are Synlogic's key executives?

Synlogic's management team includes the following people:
  • Dr. Aoife M. Brennan M.D., MB, BCh, BAO, MMSc, Pres, CEO & Director (Age 44, Pay $737.3k)
  • Dr. Richard J. Riese M.D., Ph.D., Chief Medical Officer (Age 57, Pay $209.16k)
  • Prof. Timothy K. Lu, Co-Founder
  • Dr. James J. Collins, Co-Founder (Age 54)
  • Mr. Gregg D. Beloff, Interim CFO, Principal Acounting Officer & Principal Financial Officer (Age 52)
  • Mr. Antoine Awad, Chief Operating Officer
  • Mr. Daniel Rosan, Head of Corp. Fin. & Investor Relations
  • Dr. David L. Hava, Chief Scientific Officer (Age 45)
  • Dr. Elizabeth Wolffe, Head of Investor Relations & Corp. Communications
  • Mr. Adam Thomas, Chief People Officer & Sec.

What is Synlogic's stock symbol?

Synlogic trades on the NASDAQ under the ticker symbol "SYBX."

Who are Synlogic's major shareholders?

Synlogic's stock is owned by a variety of institutional and retail investors. Top institutional investors include Jane Street Group LLC (0.07%), Acadian Asset Management LLC (0.06%), Bank Julius Baer & Co. Ltd Zurich (0.06%) and Morgan Stanley (0.05%). Company insiders that own Synlogic stock include Paul Francis Miller and Richard P Shea.
View institutional ownership trends for Synlogic
.

Which major investors are selling Synlogic stock?

SYBX stock was sold by a variety of institutional investors in the last quarter, including Jane Street Group LLC, and Morgan Stanley.
View insider buying and selling activity for Synlogic
.

Which major investors are buying Synlogic stock?

SYBX stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, and Bank Julius Baer & Co. Ltd Zurich.
View insider buying and selling activity for Synlogic
.

How do I buy shares of Synlogic?

Shares of SYBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Synlogic's stock price today?

One share of SYBX stock can currently be purchased for approximately $2.12.

How big of a company is Synlogic?

Synlogic has a market capitalization of $73.85 million and generates $2.22 million in revenue each year. The biotechnology company earns $-51,370,000.00 in net income (profit) each year or ($1.70) on an earnings per share basis. Synlogic employs 76 workers across the globe.

What is Synlogic's official website?

The official website for Synlogic is www.synlogictx.com.

How can I contact Synlogic?

Synlogic's mailing address is 301 Binney St. Suite 402, Cambridge MA, 02142. The biotechnology company can be reached via phone at 617-401-9975 or via email at [email protected]

This page was last updated on 11/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.